SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies (ROLR) is experiencing a massive surge following its binding Letter of Intent with crypto.com/us to launch a US prediction markets product. This low-float stock is driving intense community discussion around a potential multi-day run and a significant short squeeze, though some caution against a possible pump and dump. Sentiment is highly speculative, with many anticipating continued upward momentum due to the crypto-adjacent hype.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial (RILY) is trending following the filing of its overdue Q3 2025 financial report, which has brought the company into NASDAQ compliance and showcased strong quarterly performance. This catalyst is fueling widespread community speculation of a massive short squeeze, with a significant portion of the float currently shorted, as traders anticipate a sharp price move and potential institutional buying. The ongoing discussion highlights RILY's perceived undervaluation and the pressure on short sellers as the company resolves its reporting issues.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is experiencing heightened attention driven by its presentation at the J.P. Morgan Healthcare Conference, where investors anticipate updates on new partnerships for its Matrix-M platform and a strategic outlook. The community buzzes with speculation about a potential short squeeze due to high short interest, while challenging management to secure decisive new collaborations beyond its existing COVID-19 vaccine.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is a major talking point after recent discussions highlighted the increasing capital expenditures required for its AI infrastructure, including remarks about tech companies bearing their own data center electricity costs. Community sentiment is sharply divided, with some investors seeing a strong buying opportunity in its AI leadership, while others voice concerns over competition and potential impacts on profitability.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is trending due to a widespread network outage affecting wireless services across the nation, leading to significant user frustration and calls for service reliability. The community is actively debating the cause, with speculation ranging from potential cyberattacks to underlying network issues, while questioning the stock's stability amidst discussions of customer retention challenges.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is experiencing heightened investor interest and robust trading volume, driven by conviction in its Optical Interposer technology as a critical solution for high-speed, energy-efficient AI data center connectivity. The community is actively discussing the company's strategic partnerships and anticipating significant announcements, believing POET is poised for substantial growth in the rapidly expanding photonics sector.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company (ABAT) is trending with strong bullish sentiment driven by rising lithium prices and its prominent role in critical mineral discussions, including leadership engagement at a G7 summit. The community is highlighting technical buy signals, the significance of its battery recycling operations, including updates on the Moss Landing contract and claystone plant, and anticipating catalysts such as DOE grants and EXIM financing for future expansion. This positions ABAT as a key domestic player in the evolving battery and critical minerals sector.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is actively discussed amidst escalating geopolitical developments in the Middle East and notable sector rotation out of key tech names, sparking significant intraday volatility. Despite these mixed signals and increased market fear, many in the community continue to advocate for buying dips, reflecting persistent bullish sentiment. This dynamic keeps broader market direction a central talking point as participants assess global stability.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is trending intensely amid a powerful rally, driven by discussions around surging physical demand, significantly higher silver prices in Asian markets, and reports of the US Mint halting sales. Community members are passionately debating whether this parabolic move is a sustainable repricing due to industrial demand and supply deficits or a speculative bubble poised for a sharp correction, with many anticipating continued upward momentum or a significant pullback.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending as Bitcoin gains momentum, fueling speculation around upcoming legislative decisions like the Digital Asset Market CLARITY Act. While many bulls view COIN as a potential beneficiary of a more regulated crypto landscape and expanding product offerings, community sentiment is sharply divided, with deep frustration voiced over its perceived underperformance compared to broader crypto market moves.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ELTX Here’s my personal summary, in case it helps anyone: 
 
Phase 1 
 • RFS (single-arm): 16 months in MRD+ patients (historical DFS ~3–4 months) → very strong result. 
 • Subgroups are not relevant since all patients are in one arm in Phase 2. 
 • HR: 0.12 (88% lower risk of death). 
Even though intra-arm, assuming non-responders ≈ placebo, a true placebo comparison could improve this. 
 
⸻ 
 
Phase 2 – where improvement should come from 
 • Including MRD+ and MRD− patients should increase absolute DFS, but that alone doesn’t mean better efficacy. 
 • Real improvement drivers: 
 • Higher response rate: 99% (P2) vs. 84% (P1) 
 • Greater depth: fold-change x44 vs. x13 
 • Better immune quality: CD4+/CD8+ activation 85% vs. 71% 
 • Antigen spreading 
 
⸻ 
 
HR outlook 
 • HR may worsen by including non-responders, but fewer and better-performing non-responders should offset this. 
 • Control is saline; using historical DFS of 10–14 months, control and non-responders should behave similarly. 
 
⸻ 
 
Corrections welcome.

Cbra

raj c

StockTwits Web

Elicio Therapeutics Inc

 Here’s my personal summary, in case it helps anyone: 
 
Phase 1 
 • RFS (single-arm): 16 months in MRD+ patients (historical DFS ~3–4 months) → very strong result. 
 • Subgroups are not relevant since all patients are in one arm in Phase 2. 
 • HR: 0.12 (88% lower risk of death). 
Even though intra-arm, assuming non-responders ≈ placebo, a true placebo comparison could improve this. 
 
⸻ 
 
Phase 2 – where improvement should come from 
 • Including MRD+ and MRD− patients should increase absolute DFS, but that alone doesn’t mean better efficacy. 
 • Real improvement drivers: 
 • Higher response rate: 99% (P2) vs. 84% (P1) 
 • Greater depth: fold-change x44 vs. x13 
 • Better immune quality: CD4+/CD8+ activation 85% vs. 71% 
 • Antigen spreading 
 
⸻ 
 
HR outlook 
 • HR may worsen by including non-responders, but fewer and better-performing non-responders should offset this. 
 • Control is saline; using historical DFS of 10–14 months, control and non-responders should behave similarly. 
 
⸻ 
 
Corrections welcome.